TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT03691519 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT01949220 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT01884246 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03775096 — Safety Biomarker (SAF): SLC6A3
Genes: DAT
Study NCT02395250 — Predictive Biomarker (PRD): GPC3 mRNA
Genes: GPC3; OCI5
Study NCT02997228 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT02123264 — Predictive Biomarker (PRD): TNFRSF11B mRNA
Genes: TNFRSF11B; OCIF; OPG
Study NCT03534687 — Predictive Biomarker (PRD): AGER mRNA
Genes: AGER; RAGE
Study NCT01199939 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03941808 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT00400374 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00400374 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03858972 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03858972 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT03858972 — Predictive Biomarker (PRD): Hormone receptor
Study NCT02151981 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02826434 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT04205305 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00050531 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02408861 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT00160849 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03511105 — Predictive Biomarker (PRD): TRPV4 mRNA
Genes: TRPV4; VRL2; VROAC
Study NCT04585594 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02507180 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT03465462 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01697163 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01697163 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT01697163 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study NCT01697163 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01871259 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00407134 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02925962 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02073994 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT01918683 — Predictive Biomarker (PRD): ADAM17 mRNA
Genes: ADAM17; CSVP; TACE
Study NCT01779843 — Predictive Biomarker (PRD): Aurora kinase A
Genes: AURKA; AIK; AIRK1; ARK1; AURA; AYK1; BTAK; IAK1; STK15; STK6
Study NCT02001311 — Surrogate Endpoint (SUR): Bacterial count
Study NCT00048386 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT02347813 — Predictive Biomarker (PRD): AKR1C3 mRNA
Genes: AKR1C3; DDH1; HSD17B5; KIAA0119; PGFS
Study NCT03526328 — Predictive Biomarker (PRD): DCLK1 mRNA
Genes: DCLK1; DCAMKL1; DCDC3A; KIAA0369
Study NCT04507724 — Safety Biomarker (SAF): Myeloperoxidase
Genes: MPO
Study NCT01628497 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT01402076 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT03473730 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT01443468 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT02944227 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02944227 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02433184 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03653507 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01310179 — Predictive Biomarker (PRD): PNP mRNA
Genes: PNP; NP
Study NCT01874275 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT05797532 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04257175 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT03069170 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT01618383 — Pharmacodynamic Biomarker (PDY): Leucine-rich repeat kinase 2
Genes: LRRK2; PARK8
Study NCT01480713 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04413539 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT01445509 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01445509 — Predictive Biomarker (PRD): PTK2 mRNA
Genes: PTK2; FAK; FAK1
Study NCT03992755 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT02140151 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT05852418 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT04294628 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01941979 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT02240212 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04465032 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03801005 — Predictive Biomarker (PRD): CD200 mRNA
Genes: CD200; MOX1; MOX2; My033
Study NCT03801005 — Predictive Biomarker (PRD): PGP mRNA
Genes: PGP
Study NCT03801005 — Predictive Biomarker (PRD): Multidrug resistance protein 1
Genes: ABCB1; MDR1; PGY1
Study NCT01505673 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04120753 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02116335 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study NCT03289039 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00574782 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT00574782 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00574782 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT05210517 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT00369174 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study NCT04038047 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT03868956 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT01988662 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01988662 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00128635 — Predictive Biomarker (PRD): TNNT1 mRNA
Genes: TNNT1; TNT
Study NCT02069639 — Predictive Biomarker (PRD): CCL17 mRNA
Genes: CCL17; SCYA17; TARC
Study NCT00502242 — Predictive Biomarker (PRD): SRL mRNA
Genes: SRL
Study NCT03465579 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT04651933 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT04651933 — Predictive Biomarker (PRD): Homologous recombination deficiency
Study NCT02850146 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT03507868 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT01739205 — Predictive Biomarker (PRD): PICALM mRNA
Genes: PICALM; CALM
Study NCT01739205 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04494386 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT01611883 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT02729025 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT03101631 — Predictive Biomarker (PRD): CGA mRNA
Genes: CGA
Study NCT00005901 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01872039 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02535026 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04437966 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01741324 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04640519 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06799143 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00195143 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT00086619 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01738932 — Predictive Biomarker (PRD): MBL2 mRNA
Genes: MBL2; COLEC1; MBL
Study NCT06606340 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT04029584 — Safety Biomarker (SAF): SLCO1B1
Genes: OATP-C; LST-1; OATP1B1
Study NCT03948516 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT00966992 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02968160 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02968160 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT04193761 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT01414101 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02728544 — Predictive Biomarker (PRD): UCP1 mRNA
Genes: UCP1; SLC25A7; UCP
Study NCT02728544 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT01089023 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00025428 — Predictive Biomarker (PRD): MYCN mRNA
Genes: MYCN; BHLHE37; NMYC
Study NCT04123912 — Predictive Biomarker (PRD): DCD mRNA
Genes: DCD; AIDD; DSEP
Study NCT04018976 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04366947 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01900106 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01900106 — Predictive Biomarker (PRD): RALA mRNA
Genes: RALA; RAL
Study NCT02545114 — Surrogate Endpoint (SUR): Serum sodium
Study NCT00278369 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 2 receptor alpha
Genes: IL2RA
Study NCT00278369 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT02680639 — Pharmacodynamic Biomarker (PDY): High-frequency oscillations
Study NCT01297361 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT04610489 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01955434 — Predictive Biomarker (PRD): DIABLO mRNA
Genes: DIABLO; SMAC
Study NCT00805714 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT03147612 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT03147612 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT03300817 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Mucin-1
Genes: MUC1; PUM
Study NCT01445730 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT03457142 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study NCT03457142 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT03701113 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04167163 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01398332 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study NCT04552210 — Predictive Biomarker (PRD): MBL2 mRNA
Genes: MBL2; COLEC1; MBL
Study NCT02694913 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT02694913 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT00091871 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT03705403 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT00314119 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT01413100 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03991403 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03991403 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT04527237 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00001532 — Predictive Biomarker (PRD): TSC2
Genes: tuberin; LAM; PPP1R160
Study NCT01562522 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study NCT05280002 — Predictive Biomarker (PRD): KL mRNA
Genes: KL
Study NCT00368836 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT02444546 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04253106 — Predictive Biomarker (PRD): Epithelial cadherin
Genes: CDH1; CDHE; UVO
Study NCT04253106 — Predictive Biomarker (PRD): CTNNA1 mRNA
Genes: CTNNA1
Study NCT00038402 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02092376 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03220022 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT02110329 — Predictive Biomarker (PRD): DCC mRNA
Genes: DCC; IGDCC1
Study NCT02110329 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02110329 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT02110329 — Predictive Biomarker (PRD): BLK mRNA
Genes: BLK
Study NCT02110329 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study NCT02110329 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02110329 — Predictive Biomarker (PRD): HMBS mRNA
Genes: HMBS; PBGD; UPS
Study NCT04002284 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01240525 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04579484 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04579484 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT04579484 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT04579484 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01534260 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT02482194 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT02421380 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study NCT03907904 — Safety Biomarker (SAF): Cytochrome c
Study NCT03907904 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01456208 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04556305 — Safety Biomarker (SAF): BDNF
Study NCT00457821 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT02298179 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT03537742 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT00801489 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study NCT03832855 — Predictive Biomarker (PRD): ERBB3 mRNA
Genes: ERBB3; HER3
Study NCT03832855 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03648489 — Predictive Biomarker (PRD): TP53INP2 mRNA
Genes: TP53INP2; C20orf110; DOR; PINH
Study NCT03648489 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study NCT00967785 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study NCT00967785 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00967785 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT01426919 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study NCT01989780 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04265508 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): TNF related activation protein
Genes: CD40LG; CD40L; TNFSF5; TRAP
Study NCT03412136 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT01251900 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT01251900 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT03279523 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT01362803 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT03832114 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study NCT02644954 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02791191 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT02821780 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04637503 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT04637503 — Predictive Biomarker (PRD): CD276 mRNA
Genes: CD276; B7H3; PSEC0249; UNQ309/PRO352
Study NCT01593670 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT01593670 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT03267173 — Predictive Biomarker (PRD): PSCA mRNA
Genes: PSCA; UNQ206/PRO232
Study NCT03267173 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT03267173 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03267173 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Mucin-1
Genes: MUC1; PUM
Study NCT05186831 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00879307 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT00879307 — Safety Biomarker (SAF): BDNF
Study NCT02808182 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT04046445 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT04086537 — Predictive Biomarker (PRD): BMPR2 mRNA
Genes: BMPR2; PPH1
Study NCT04086537 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT01686763 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study NCT00537667 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01239810 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT02337829 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT03784014 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study NCT03784014 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study NCT01874769 — Predictive Biomarker (PRD): COL7A1 mRNA
Genes: COL7A1
Study NCT04175847 — Predictive Biomarker (PRD): MSLN mRNA
Genes: MSLN; MPF
Study NCT03526835 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04218084 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT00435162 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00024661 — Predictive Biomarker (PRD): RAF1 mRNA
Genes: RAF1; RAF
Study NCT01646645 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT05682456 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study NCT00018044 — Predictive Biomarker (PRD): NTM mRNA
Genes: NTM; IGLON2; NT; UNQ297/PRO337
Study NCT04563507 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04563507 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04563507 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04422912 — Predictive Biomarker (PRD): DSG3 mRNA
Genes: DSG3; CDHF6
Study NCT04422912 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04185883 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT01550341 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01213186 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT01213186 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04531358 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT00011414 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02952482 — Predictive Biomarker (PRD): ABCD1 mRNA
Genes: ABCD1; ALD
Study NCT03764917 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03764917 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT01140568 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study NCT00072644 — Predictive Biomarker (PRD): Multidrug resistance protein 1
Genes: ABCB1; MDR1; PGY1
Study NCT02414945 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT02872714 — Predictive Biomarker (PRD): FGFR3 mRNA
Genes: FGFR3; JTK4
Study NCT01688739 — Pharmacodynamic Biomarker (PDY): Dermal blood flow
Study NCT03769415 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT03769415 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03769415 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04318366 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04361773 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04151186 — Predictive Biomarker (PRD): TM4SF1 mRNA
Genes: TM4SF1; M3S1; TAAL6
Study NCT01559077 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT03786588 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT03786588 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT00996801 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03121677 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT02844413 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04446260 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04535141 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05756595 — Predictive Biomarker (PRD): CD44 mRNA
Genes: CD44; LHR; MDU2; MDU3; MIC4
Study NCT05756595 — Predictive Biomarker (PRD): TLR2 mRNA
Genes: TLR2; TIL4
Study NCT05756595 — Predictive Biomarker (PRD): CEMIP mRNA
Genes: CEMIP; KIAA1199
Study NCT05756595 — Predictive Biomarker (PRD): TRPV1 mRNA
Genes: TRPV1; VR1
Study NCT04354064 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT02187276 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT02187276 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1